Back to search
FDAFDA · Food and drugs·Recall number Z-2034-2012

epoc Blood Analysis BGEM Test Cards for use with the epoc(R) Blood Analysis System Product Usage: Usage: epoc Blood Analysis BGEM Test Cards are used with the epoc(R) Blood Analysis System which is a POC testing system

Published July 25, 2012 · Recall initiated: June 28, 2011

Summary

FDA records medical device Class II recall Z-2034-2012, published July 25, 2012 and initiated June 28, 2011. Recalling firm: Epocal Inc; Status: Terminated; Reported quantity: 8,650; Lot: Catalog #CT-1004-00-00, lot number 07-11087-00. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Customer reported problem while performing incoming QC of newly received lot of test cards. Liquid quality control results were found to be out of range. Further investigation by Epocal determined that a portion of the test card lot (approximately 3000 cards) could potentially report low glucose results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Epocal Inc
Distributor
US nationwide Distribution in the state of CA.
Lot
Catalog #CT-1004-00-00, lot number 07-11087-00
Risk classification
Class II
Area (FDA)
device
Country
Canada

Related recalls

Questions about this recall

Was epoc Blood Analysis BGEM Test Cards for use with the epoc(R) Blood Analysis System Product Usage: Usage: epoc Blood Analysis BGEM Test Cards are used with the epoc(R) Blood Analysis System which is a POC testing system recalled?

Yes. FDA published recall Z-2034-2012 on July 25, 2012. Reported hazard: Customer reported problem while performing incoming QC of newly received lot of test cards. Liquid quality control results were found to be out of range. Further investigation by Epocal determined that a portion of the test card lot (approximately 3000 cards) could potentially report low glucose results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter